Company
LON:IMM
ImmuPharma PLC is a biopharmaceutical company that specializes in the usage and development of biopolymers, specifically peptides. The company is dedicated to developing an innovative portfolio of peptide-based therapeutic drugs with a focus on autoimmunity/inflammation and anti-infectives.
306 stories · page 10 of 16
Chairman Tim McCarthy said: "With the continued robust safety record of Lupuzor achieved over this trial, we look forward with confidence to reporting top line results in the near future"
Will EU leaders approve the Brexit transition deal reached between Michel Barnier and David Davis?
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of today's top risers and fallers in London today
Investments and investor services
The UK's blue-chip index closes up 20.84 points to 7,234.81
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Premaitha is given a fillip by permission to appeal against High Court's decision on patent dispute
The cash, raised by issuing shares at 144p each, will support future investment in the P140 peptide platform
Investments and investor services
“If he intended it, Treasury Secretary Steven Mnuchin has done a first class job of whacking the dollar,” declared Neil Wilson at ETX Capital. .
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at some of the top risers and fallers in London today.
The last of the 200 patients has had their final assessment and the data is now being processed and analysed
Investments and investor services
The FTSE 100 closed lower on Thursday as there was no clear direction across global equities
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Thursday
ImmuPharma’s chairman, Tim McCarthy, said: "Importantly we continue to see robust safety and we look forward with continued confidence to reporting top line results of the study in Q1 2018"
Investments and investor services
The FTSE 100 index closed up 78 points at 7,603, just off the all time high
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the top risers and fallers in London today
